Scholar Rock Holding Debt to Equity Ratio 2017-2020 | SRRK

Current and historical debt to equity ratio values for Scholar Rock Holding (SRRK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Scholar Rock Holding debt/equity for the three months ending March 31, 2020 was 0.04.
Scholar Rock Holding Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-03-31 $0.00B $0.10B 0.04
2019-12-31 $0.00B $0.11B 0.04
2019-09-30 $0.00B $0.12B 0.04
2019-06-30 $0.01B $0.13B 0.04
2019-03-31 $0.01B $0.10B 0.05
2018-12-31 $0.00B $0.11B 0.00
2018-09-30 $0.00B $0.10B 0.00
2018-06-30 $0.00B $0.11B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $0.00B 0.00
2017-09-30 $0.00B 0.00
2017-06-30 $0.00B 0.00
2016-12-31 $0.00B $-0.03B -0.03
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.381B $0.020B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.877B 15.73
Bristol Myers Squibb (BMY) United States $133.725B 11.17
CSL (CSLLY) Australia $90.574B 0.00
Gilead Sciences (GILD) United States $89.976B 12.95
Vertex Pharmaceuticals (VRTX) United States $72.806B 40.63
Regeneron Pharmaceuticals (REGN) United States $70.981B 27.36
Illumina (ILMN) United States $58.485B 60.10
Biogen (BIIB) United States $44.036B 7.54
Seattle Genetics (SGEN) United States $29.412B 0.00
Moderna (MRNA) United States $28.948B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.547B 0.00
Genmab (GMAB) Denmark $23.368B 19.23
Alexion Pharmaceuticals (ALXN) United States $22.980B 9.58
Genmab (GNMSF) Denmark $22.277B 66.14
Incyte (INCY) United States $22.126B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.069B 200.07
BeiGene (BGNE) Cayman Islands $19.808B 0.00
BioNTech SE (BNTX) Germany $19.339B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.569B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.496B 70.16
Exact Sciences (EXAS) United States $14.278B 0.00
Galapagos (GLPG) Belgium $12.647B 37.20
Sarepta Therapeutics (SRPT) United States $12.340B 0.00
Horizon Therapeutics Public (HZNP) Ireland $12.032B 29.61
ARGENX SE-ADR (ARGX) Netherlands $11.190B 0.00
QIAGEN (QGEN) Netherlands $11.144B 32.40
Bio-Techne Corp (TECH) United States $10.659B 70.42
Immunomedics (IMMU) United States $10.254B 0.00
Novavax (NVAX) United States $9.034B 0.00
Repligen (RGEN) United States $8.310B 131.89
Guardant Health (GH) United States $8.136B 0.00
Ascendis Pharma (ASND) Denmark $7.614B 0.00
Exelixis (EXEL) United States $7.265B 25.47
ACADIA Pharmaceuticals (ACAD) United States $6.744B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.491B 201.09
Emergent Biosolutions (EBS) United States $6.245B 24.74
Vir Biotechnology (VIR) United States $5.839B 0.00
Acceleron Pharma (XLRN) United States $5.668B 0.00
Mirati Therapeutics (MRTX) United States $5.546B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.062B 0.00
Adaptive Biotechnologies (ADPT) United States $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.962B 0.00
Zai Lab (ZLAB) China $4.663B 0.00
MorphoSys AG (MOR) Germany $4.534B 35.16
MyoKardia (MYOK) United States $4.498B 0.00
Global Blood Therapeutics (GBT) United States $4.295B 0.00
NeoGenomics (NEO) United States $4.263B 1286.67
China Biologic Products (CBPO) China $4.196B 23.33
Blueprint Medicines (BPMC) United States $4.154B 0.00
Halozyme Therapeutics (HALO) United States $3.850B 0.00
Amicus Therapeutics (FOLD) United States $3.847B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.808B 0.00
Bluebird Bio (BLUE) United States $3.494B 0.00
Inovio Pharmaceuticals (INO) United States $3.271B 0.00
Arena Pharmaceuticals (ARNA) United States $3.189B 0.00
Alkermes (ALKS) Ireland $2.971B 62.27
Principia Biopharma (PRNB) United States $2.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.763B 0.00
Insmed (INSM) United States $2.743B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
Fate Therapeutics (FATE) United States $2.580B 0.00
Denali Therapeutics (DNLI) United States $2.563B 0.00
Twist Bioscience (TWST) United States $2.417B 0.00
Sorrento Therapeutics (SRNE) United States $2.049B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.911B 64.72
UniQure (QURE) Netherlands $1.893B 0.00
Viela Bio (VIE) United States $1.879B 0.00
Editas Medicine (EDIT) United States $1.744B 0.00
I-Mab (IMAB) China $1.735B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.693B 0.00
Mesoblast (MESO) Australia $1.678B 0.00
Sangamo Therapeutics (SGMO) United States $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.579B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.556B 0.00
Zymeworks (ZYME) Canada $1.478B 0.00
Epizyme (EPZM) United States $1.452B 0.00
Adverum Biotechnologies (ADVM) United States $1.436B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.405B 0.00
Revance Therapeutics (RVNC) United States $1.398B 0.00
Intra-Cellular Therapies (ITCI) United States $1.389B 0.00
Mersana Therapeutics (MRSN) United States $1.383B 0.00
Cytokineticsorporated (CYTK) United States $1.348B 0.00
Coherus BioSciences (CHRS) United States $1.293B 9.02
NGM Biopharmaceuticals (NGM) United States $1.287B 0.00
REGENXBIO (RGNX) United States $1.278B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Arvinas (ARVN) United States $1.264B 0.00
Alector (ALEC) United States $1.223B 0.00
NantKwest (NK) United States $1.186B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.177B 0.00
Alcobra (ARCT) United States $1.113B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.109B 0.00
Akcea Therapeutics (AKCA) United States $1.104B 0.00
Compugen (CGEN) Israel $1.082B 0.00
Retrophin (RTRX) United States $1.026B 0.00
VBI Vaccines (VBIV) United States $0.999B 0.00
Intellia Therapeutics (NTLA) United States $0.989B 0.00
Beam Therapeutics (BEAM) United States $0.978B 0.00
Arcus Biosciences (RCUS) United States $0.970B 0.00
Heska (HSKA) United States $0.951B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Myriad Genetics (MYGN) United States $0.928B 47.88
Athenex (ATNX) United States $0.915B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.840B 0.00
Dynavax Technologies (DVAX) United States $0.826B 0.00
Cara Therapeutics (CARA) United States $0.802B 0.00
Vericel (VCEL) United States $0.775B 143.25
Intrexon (PGEN) United States $0.768B 0.00
Cellectis S.A (CLLS) France $0.743B 0.00
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Morphic Holding (MORF) United States $0.723B 0.00
Codexis (CDXS) United States $0.718B 0.00
Castle Biosciences (CSTL) United States $0.694B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.681B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.637B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Kadmon Holdings (KDMN) United States $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.577B 4.94
Cue Biopharma (CUE) United States $0.566B 0.00
Agenus (AGEN) United States $0.559B 0.00
IBio (IBIO) United States $0.535B 0.00
Athersys (ATHX) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.527B 0.00
Prothena (PRTA) Ireland $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.506B 22.16
Kala Pharmaceuticals (KALA) United States $0.506B 0.00
AnaptysBio (ANAB) United States $0.503B 0.00
Prometic Life Sciences (LMNL) Canada $0.503B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.492B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Clovis Oncology (CLVS) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.465B 0.00
Protagonist Therapeutics (PTGX) United States $0.452B 0.00
DBV Technologies S.A (DBVT) France $0.450B 0.00
BioDelivery Sciences (BDSI) United States $0.446B 23.42
Puma Biotechnology (PBYI) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.403B 0.00
Kamada (KMDA) Israel $0.402B 16.70
Merus (MRUS) Netherlands $0.400B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.395B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.379B 333.00
ANI Pharmaceuticals (ANIP) United States $0.368B 7.16
Geron (GERN) United States $0.360B 0.00
MannKind (MNKD) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.341B 0.00
CytomX Therapeutics (CTMX) United States $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.320B 0.00
ChromaDex (CDXC) United States $0.317B 0.00
Trevena (TRVN) United States $0.315B 0.00
Seres Therapeutics (MCRB) United States $0.312B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
ADMA Biologics Inc (ADMA) United States $0.292B 0.00
OSMOTICA PHARM (OSMT) United States $0.292B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Menlo Therapeutics (MNLO) United States $0.288B 0.00
Pluristem Therapeutics (PSTI) Israel $0.281B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Starpharma Holdings (SPHRY) Australia $0.270B 0.00
Cellular Biomedicine (CBMG) United States $0.269B 0.00
Arbutus Biopharma (ABUS) United States $0.264B 0.00
Northwest Biotherapeutics (NWBO) United States $0.264B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
NextCure (NXTC) United States $0.254B 0.00
Pfenex (PFNX) United States $0.252B 0.00
Celldex Therapeutics (CLDX) United States $0.250B 0.00
Dyadic (DYAI) United States $0.249B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Selecta Biosciences (SELB) United States $0.231B 0.00
Verastem (VSTM) United States $0.231B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.221B 0.00
IVERIC Bio (ISEE) United States $0.220B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Exicure (XCUR) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
XOMA (XOMA) United States $0.190B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
Aptinyx (APTX) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.175B 0.00
Liquidia Technologies (LQDA) United States $0.165B 0.00
Cerecor (CERC) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.161B 0.00
Bellus Health (BLU) Canada $0.160B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.141B 0.00
TELA Bio (TELA) United States $0.139B 0.00
Kindred Biosciences (KIN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Palatin Technologies (PTN) United States $0.135B 3.47
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Gritstone Oncology (GRTS) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Enzo Biochem (ENZ) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.110B 0.00
CorMedix Inc (CRMD) United States $0.109B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.109B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.106B 0.00
AquaBounty Technologies (AQB) United States $0.105B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
Unum Therapeutics (UMRX) United States $0.085B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Proteostasis Therapeutics (PTI) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
IMMURON (IMRN) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
OvaScience (MLND) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.031B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00